From January 1, 2024 to March 29, 2024, the company has repurchased 1,193,693 shares, representing 0.88% for $150 million. With this, the company has completed the repurchase of 8,162,374 shares, representing 5.89% for $904.6 million under the buyback announced on February 15, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
145.5 USD | -1.04% | -3.72% | +34.44% |
Jun. 03 | Wells Fargo Adjusts Price Target on Leidos Holdings to $168 From $158 | MT |
May. 23 | TFF Pharmaceuticals, Leidos to Advance Biodefense Countermeasures Into Preclinical Testing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.44% | 19.68B | |
-19.71% | 177B | |
-1.86% | 161B | |
+1.06% | 152B | |
+4.74% | 99.88B | |
+10.96% | 81.66B | |
+20.90% | 74.66B | |
-9.41% | 70.05B | |
-31.19% | 45.84B | |
-10.86% | 42.83B |
- Stock Market
- Equities
- LDOS Stock
- News Leidos Holdings, Inc.
- Tranche Update on Leidos Holdings, Inc.'s Equity Buyback Plan announced on February 15, 2022.